Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MiniMed

This article was originally published in The Gray Sheet

Executive Summary

Plans an April 1995 submission, with partner Hoechst, of a premarket approval application for an implantable insulin pump for diabetes, company COO Peter Rule tells analysts Nov. 29 at the Robertson Stephens medical conference in New York. The pump is placed subcutaneously in the abdominal area and the catheter is then "tunneled into the peritoneal area" to dispense insulin, Rule said. The PMA will be accompanied by a new drug application for the concentrated insulin to be used with the device. Hoechst will manufacture the drug
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003163

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel